Restored Cytokine-Producing Capacities of Mucosal-associated Invariant T Cells in Pediatric Cystic Fibrosis Patients Treated with Elexacaftor/Tezacaftor/Ivacaftor

MeSH terms

• Adolescent
• Aminophenols* / therapeutic use
• Benzodioxoles* / therapeutic use
• Child
• Child, Preschool
• Cystic Fibrosis* / drug therapy
• Cytokines* / metabolism
• Drug Combinations
• Female
• Humans
• Indoles* / therapeutic use
• Male
• Mucosal-Associated Invariant T Cells* / drug effects
• Mucosal-Associated Invariant T Cells* / immunology
• Pyrazoles* / therapeutic use
• Pyridines / therapeutic use
• Pyrroles / therapeutic use
• Pyrrolidines
• Quinolines / therapeutic use
• Quinolones* / therapeutic use